Breast Cancer News and Research

Latest Breast Cancer News and Research

Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer

Efforts to treat cancer using genes and other oligonucleotides, such as short interfering RNA (siRNA), that turn off the biochemical processes that trigger malignancies have been hindered by difficulties in delivering nucleic acids to tumors.

16 Oct 2006

A pill a day gives renewed hope for breast cancer victims

A new breast cancer 'wonder drug' could be available to British women within a matter of months.

9 Oct 2006

New York Times examines efforts to obtain FDA approval for Abraxane to treat earlier-stage cancer

The New York Times has examined efforts by the pharmaceutical company Abraxis BioScience to obtain FDA approval for its late-stage breast cancer drug Abraxane as a treatment for earlier-stage breast cancer.

5 Oct 2006

FDA more cautious in approving new drugs after Vioxx

Many pharmaceutical companies and industry observers say that FDA is "quietly becoming more assertive about keeping new drugs off the market or refusing to approve new uses for existing medications" in response to criticism since the 2004 Vioxx recall, the New York Times reports.

3 Oct 2006

Super chow, laced with semi-synthetic vitamin E derivative, inhibited spread of cancer in mice

A chemically altered form of vitamin E mixed into mouse chow dramatically reduced spread of aggressive mammary cancer in mice, suggesting that the compound in pill form could be used to treat human metastatic cancer, according to a report in the October 1 issue of the journal Cancer Research.

2 Oct 2006

Direct observations of DNA provides new insights into how genetic material is copied and repaired

"We can monitor the process directly, and that gives us a different perspective," said Roberto Galletto, a postdoctoral scholar at UC Davis and first author on a paper published Sept. 20 on the Web site of the journal Nature.

21 Sep 2006

New target for cancer therapy identified by Australian researchers

A new target for cancer therapy has been identified by Monash University scientists investigating the cell signalling pathways that turn on a gene involved in cancer development.

21 Sep 2006

GSK seeks regulatory approval in U.S., Europe for Tykerb

GlaxoSmithKline on Monday said it has submitted its experimental breast cancer drug Tykerb, which is taken orally, for FDA approval and plans to file for approval in Europe in the fourth quarter of this year, Reuters reports.

20 Sep 2006

BlueCross BlueShield of Illinois adds coverage for MammoSite

BlueCross BlueShield of Illinois after meeting with experts last week has decided to cover the partial-breast radiation therapy known as MammoSite for patients with early stage breast cancer, officials for the insurer said, the Chicago Sun-Times reports.

20 Sep 2006

Jury dismisses lawsuit against Wyeth in first Pempro case

A jury in a U.S. District Court in Little Rock, Ark., on Friday dismissed negligence charges in the first of about 5,000 lawsuits filed over Prempro, a combination hormone replacement therapy manufactured by Wyeth, and found the drug's design was not defective, Reuters reports.

20 Sep 2006

Aromatase inhibitors improve survival of advanced breast cancer patients compared to tamoxifen

Aromatase inhibitors improve the survival of advanced breast cancer patients compared to standard hormone therapies like tamoxifen, a researchers report in the September 20 issue of the Journal of the National Cancer Institute.

19 Sep 2006

Having breast implants does not increase mortality risk

A study conducted among 24,600 women by two Universiti Laval Faculty of Medicine researchers and their colleagues from the Canadian Public Health Agency and Cancer Care Ontario concludes that having breast implants does not increase mortality risk.

19 Sep 2006

Breast cancer incidence is lower for Latinas

Breast cancer incidence is lower for Latinas than for non-Latina white women, but Latinas diagnosed with the disease are more likely to die than white women, according to a report released by the American Cancer Society, Long Island Newsday reports.

18 Sep 2006

Black women living in South Carolina are more likely to develop cancers

Black women living in South Carolina are more likely to develop and die from breast and cervical cancers, compared to white women, according to a study published in the Journal of the South Carolina Medical Association, the AP/WHNS reports.

18 Sep 2006

Women in Government back cervical cancer vaccine for sixth graders

Girls in Michigan as young as eleven years could be the first required to be vaccinated against cervical cancer under proposed mandatory legislation.

18 Sep 2006

Raloxifene reduces breast cancer risk in postmenopausal women

Raloxifene protects postmenopausal women from developing invasive breast cancer whether they are at high or low risk of developing the disease, according to a new study.

13 Sep 2006

Australian world first in cancer therapy screening

A new approach in the treatment of breast cancer, appears to be a world first for Australian doctors.

13 Sep 2006

Could quantum dots hold the cure to cancer?

Review of quantum dot technologies for cancer detection and treatment.

13 Sep 2006

Breast and ovarian cancers linked by heredity - women need to know their risks

During September, Gynecologic Cancer Awareness Month, the Gynecologic Cancer Foundation (GCF) urges women to learn more about familial breast-ovarian cancer syndrome.

12 Sep 2006

Study's findings on breast density might complicate models for assessing breast cancer risk

A study published in the Sept. 6 edition of the Journal of the National Cancer Institute that finds breast density might be a risk factor for breast cancer could make assessment methods "considerably more complicated," the Los Angeles Times reports (Healy, Los Angeles Times, 9/11).

11 Sep 2006